Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis (Q36134754)

12 August 2017

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis (English)

1 reference

12 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

English MW

1 reference

12 August 2017

Lowis SP

1 reference

12 August 2017

Peng B

1 reference

12 August 2017

Boddy A

1 reference

12 August 2017

Newell DR

1 reference

12 August 2017

Price L

1 reference

12 August 2017

Pearson AD

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

776-780

1 reference

Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: experience of the Brazilian Wilms' Tumor Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Refining therapeutic strategies for patients with resistant Wilm's tumor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

A phase II study of ifosfamide in children with recurrent solid tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Encephalopathy in ifosfamide-treated patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

A program package for simulation and parameter estimation in pharmacokinetic systems

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Comparison of carboplatin pharmacokinetics between an anephric child and two children with normal renal function

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Pharmacokinetic evaluation of increasing dosages of etoposide in a chronic hemodialysis patient.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074374

Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function

23 September 2018

1 reference

12 December 2020

Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin

1 reference

12 December 2020

Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial

1 reference

12 December 2020

Modulation of cytotoxicity of cytostatic drugs by hemodialysis in vitro and in vivo

1 reference

12 December 2020

Successful use of cisplatin to treat metastatic seminoma during cisplatin-induced acute renal failure

1 reference

12 December 2020

Pharmacokinetics of Cis-Diammine-Dichlor-Platin in a Hemodialysis Patient

1 reference

12 December 2020

Test dose-guided administration of cisplatin in an anephric patient: a case report

1 reference

12 December 2020

Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysis-dependent renal insufficiency

1 reference

12 December 2020

Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.135

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8611379

1 reference